400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / GPCR/G Protein / GPCR / Fezagepras sodium
CAS No.: 1254472-97-3
Synonyms: Setogepram sodium;PBI-4050 sodium;PBI-4050
PBI-4050 acts as an agonist for GPR40 and as an antagonist or inverse agonist for GPR84.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02562573 | Type 2 Diabetes ... more >> Metabolic Syndrome Collapse << | Phase 2 | Completed | - | Canada, Alberta ... more >> Edmonton, Alberta, Canada Collapse << |
NCT03184584 | Alström Syndrome | Phase 2 Phase 3 | Enrolling by invitation | September 2020 | United Kingdom ... more >> University Hospitals Birmingham NHS Foundation Trus Birmingham, United Kingdom, B15 2PR Collapse << |
NCT02739217 | Inflammation and Fibrosis ... more >> Diabetes Collapse << | Phase 2 | Completed | - | United Kingdom ... more >> University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom, B15 2PR Collapse << |
实验方案
技术信息
CAS号 | 1254472-97-3 | 储存条件 |
|
|
分子式 | C13H17NaO2 | 运输 | 蓝冰 | |
分子量 | 228.26 | 别名 | Setogepram sodium;PBI-4050 sodium;PBI-4050;PBI-4050 sodium. Setogepram sodium |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02562573 | Type 2 Diabetes ... more >> Metabolic Syndrome Collapse << | Phase 2 | Completed | - | Canada, Alberta ... more >> Edmonton, Alberta, Canada Collapse << |
NCT03184584 | Alström Syndrome | Phase 2 Phase 3 | Enrolling by invitation | September 2020 | United Kingdom ... more >> University Hospitals Birmingham NHS Foundation Trus Birmingham, United Kingdom, B15 2PR Collapse << |
NCT02739217 | Inflammation and Fibrosis ... more >> Diabetes Collapse << | Phase 2 | Completed | - | United Kingdom ... more >> University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom, B15 2PR Collapse << |
NCT02538536 | Idiopathic Pulmonary Fibrosis ... more >>(IPF) Collapse << | Phase 2 | Completed | - | Canada, British Columbia ... more >> Vancouver, British Columbia, Canada Canada, Nova Scotia Halifax, Nova Scotia, Canada Canada, Ontario Toronto, Ontario, Canada Canada, Quebec Montreal, Quebec, Canada Sherbrooke, Quebec, Canada Collapse << |
NCT03081598 | Type 2 Diabetes Mellitus ... more >> Metabolic Syndrome Collapse << | Phase 2 | Terminated(Failure to meet rec... more >>ruitment target during the recruitment period) Collapse << | - | Canada, Alberta ... more >> C-Health Edmonton, Alberta, Canada Canada, Quebec Omnispec Clinical Research Mirabel, Quebec, Canada Canada LMC Clinical Research Inc. Barrie, Canada C-health - C-endo Division Calgary, Canada Centre de recherche clinique de Laval Laval, Canada Institut de Recherches Cliniques de Montreal (IRCM) Montréal, Canada LMC Clinical Research Inc. Montréal, Canada Manna Research Quebec City, Canada Synergy Medical Clinic Sherwood Park, Canada Manna Research Toronto, Canada Manna Research Vancouver, Canada Collapse << |
NCT03637049 | Healthy | Phase 1 | Active, not recruiting | September 26, 2018 | United States, Arizona ... more >> Celerion Tempe, Arizona, United States, 85283 Collapse << |
NCT02955888 | Cystic Fibrosis | Phase 2 | Terminated(Unsatisfactory rate... more >> of recruitment) Collapse << | - | Canada, British Columbia ... more >> St. Paul's Hospital - Pacific Lung Health Centre (PLHC) Vancouver, British Columbia, Canada Canada, Nova Scotia Queen Elizabeth II Health Science Center Halifax, Nova Scotia, Canada Canada, Ontario Ottawa Hospital Research Institute Ottawa, Ontario, Canada St. Michael's Hospital Toronto, Ontario, Canada Canada, Quebec Institut de Recherches Cliniques de Montréal (IRCM) Montreal, Quebec, Canada Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke Sherbrooke, Quebec, Canada Canada Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval (IUCPQ) Quebec, Canada Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网